glp-1 agonists weight loss side effects Glucagon-like Receptor-1 for obesity: outcomes, tolerability, effects, and risks ๐ GLP-1 Weight Loss Medications
Description
doi: 10.1080/13543784.2024.2377319 23
At present, oral GLP-1 tablets like Rybelsus are only available on the NHS for patients managing Type 2 diabetes who meet strict clinical criteria

Further exclusion criteria encompassed patients with pre-existing chronic liver conditions or type 1 diabetes mellitus to minimize confounding effects
The research underscores that aberrant androgen and estrogen synthesis in PCOS predominantly originates from the follicular membrane and granulosa cells, with a contributory role from the adrenal cortex

Patients receiving semaglutide (0.5 or 1.0 mg) for 104 weeks demonstrated a significantly higher risk of diabetic retinopathy complications, including vitreous hemorrhage, blindness, or required procedural treatment compared to those receiving placebo (HR, 1.76
Allulose vs erythritol